Unlocking Effective Weight Loss: The Combination of GLP-1 Agonists and Low Carb Diets
Revolutionizing the Treatment Landscape for Obesity
Glucagon-like peptide-1 (GLP-1) receptor agonists and combination medications (hereafter collectively referred to as GLP-1s) are shifting the treatment landscape for obesity. By mimicking the action of the glucagon-like peptide-1 (GLP-1) hormone, these medications can lead to significant weight loss and improved glycemic control for many patients. However, real-world challenges and limited clinician and public knowledge on nutritional and lifestyle interventions can limit GLP-1 efficacy, equitable results, and cost-effectiveness.A Powerful Science-Backed Approach: Combining Low Carb Diets with GLP-1 Medications
